Do ASARM peptides play a role in nephrogenic systemic fibrosis? - Wikidata - wikimedia - TriplyDB

Do ASARM peptides play a role in nephrogenic systemic fibrosis?

Do ASARM peptides play a role in nephrogenic systemic fibrosis?

http://www.wikidata.org/entity/Q36237106

about

Moderate Renal Failure Accentuates T1 Signal Enhancement in the Deep Cerebellar Nuclei of Gadodiamide-Treated Rats.Biological effects of MRI contrast agents: gadolinium retention, potential mechanisms and a role for phosphorus.

P2860

Q37740128-9EB044A3-2126-4B98-A93D-A7FF21383819 Q46158473-E9E177E5-B999-41BA-BACE-1B0A6EBA1913

P2860

Do ASARM peptides play a role in nephrogenic systemic fibrosis?

http://www.wikidata.org/entity/Q36237106

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Do ASARM peptides play a role in nephrogenic systemic fibrosis?

@ast

Do ASARM peptides play a role in nephrogenic systemic fibrosis?

@en

type

label

Do ASARM peptides play a role in nephrogenic systemic fibrosis?

@ast

Do ASARM peptides play a role in nephrogenic systemic fibrosis?

@en

prefLabel

Do ASARM peptides play a role in nephrogenic systemic fibrosis?

@ast

Do ASARM peptides play a role in nephrogenic systemic fibrosis?

@en

P1433

Q36237106-8F9AB624-771A-4561-A9B8-7F9D1870453E

P1476

Q36237106-6B529AD2-9811-402B-92D3-20FEBB0E8BB2

P2093

Q36237106-08AE35A6-6384-4B58-991B-66C8BF76C28B

Q36237106-113A3792-D025-447C-88A5-0C6215C1A66F

Q36237106-2B8E8219-F95C-4170-8910-6F4A9A4080F7

Q36237106-6DC58D4A-6142-485E-ABA7-9F29C84455D8

Q36237106-E2973772-9E3A-4C54-9208-669B186705F3

Q36237106-F46CF3FE-19AE-4C98-82A2-49167C7248D4

P2860

Q36237106-0C5A205E-3953-414A-BB15-0311F7C07A56

Q36237106-1C803FA8-879F-42E5-AB42-E3ECDA0E669C

Q36237106-1C92F870-691E-4A69-BA64-FEFE0BCB75A6

Q36237106-2650C865-D0BB-4417-9B65-E5A530DE56F7

Q36237106-2E4D53ED-A116-4837-9C46-A132380C4C1F

Q36237106-2EFA7B4D-CC3D-4787-A8FC-F615BDC6CEB8

Q36237106-6D3A50FF-9461-49F2-8159-925F32E91241

Q36237106-82AF0004-3538-4BEB-9E1F-3A750B3F9276

Q36237106-8C2720DE-CD0A-45AA-AACB-C32F99B1F1AC

Q36237106-8D78DF9E-8D2D-465F-8FD6-B1B0E2A2C308

P304

Q36237106-A4A3A69C-9BB1-4E2B-AF50-0FB9D9A86D1C

P31

Q36237106-E053C71F-065E-409E-A13E-6A0345A684BD

P356

Q36237106-953DE2F4-AE84-45CF-9168-17B4DB5B97AA

P433

Q36237106-9C5A952C-E912-4A3E-A13C-7FB44FAF506C

P478

Q36237106-62DF94DA-EBAF-45EA-A175-B34A8FA8308B

P577

Q36237106-0EF7BBD2-5F09-446C-B0AD-08F0A441B358

P698

Q36237106-7FC230DD-3FD1-456A-8781-D88809B48187

P932

Q36237106-2127FFC2-D6D2-42FB-8D0D-50BCC02C8A14

P356

AJPRENAL.00201.2015

P1433

American Journal of Physiology - Renal Physiology

P1476

Do ASARM peptides play a role in nephrogenic systemic fibrosis?

@en

P2093

Ellen T McCarthy

http://www.w3.org/2001/XMLSchema#string

Jennifer S Laurence

http://www.w3.org/2001/XMLSchema#string

Lesya V Zelenchuk

http://www.w3.org/2001/XMLSchema#string

Peter S N Rowe

http://www.w3.org/2001/XMLSchema#string

Phil Lee

http://www.w3.org/2001/XMLSchema#string

William M Brooks

http://www.w3.org/2001/XMLSchema#string

P2860

ASARM peptides: PHEX-dependent and -independent regulation of serum phosphate

Degradation of MEPE, DMP1, and release of SIBLING ASARM-peptides (minhibins): ASARM-peptide(s) are directly responsible for defective mineralization in HYP

Regulation of bone-renal mineral and energy metabolism: the PHEX, FGF23, DMP1, MEPE ASARM pathway

Proteolytic processing of osteopontin by PHEX and accumulation of osteopontin fragments in Hyp mouse bone, the murine model of X-linked hypophosphatemia

MEPE-ASARM peptides control extracellular matrix mineralization by binding to hydroxyapatite: an inhibition regulated by PHEX cleavage of ASARM

PHEX mimetic (SPR4-peptide) corrects and improves HYP and wild type mice energy-metabolism

Matrix extracellular phosphoglycoprotein (MEPE) is a new bone renal hormone and vascularization modulator.

Nephrogenic systemic fibrosis is associated with hypophosphataemia: a case-control study.

MEPE-derived ASARM peptide inhibits odontogenic differentiation of dental pulp stem cells and impairs mineralization in tooth models of X-linked hypophosphatemia

SPR4-peptide alters bone metabolism of normal and HYP mice.

P304

F764-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPRENAL.00201.2015

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

309

http://www.w3.org/2001/XMLSchema#string

P577

2015-09-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26336161

http://www.w3.org/2001/XMLSchema#string

P932

4628947

http://www.w3.org/2001/XMLSchema#string